-->

Company Registry

Labcyte Inc (AKA:Picoliter Inc)
Profile last edited on: 5/31/2019

Acoustic droplet ejection (ADE) technology: r pharmaceutical and life science applications
Year Founded
2000
First SBIR Year
2011
Latest SBIR Award
2011
Program Status
Inactive (Acquired)

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1190 Borregas Avenue
Sunnyvale, CA 94089
   (408) 747-2000
   team@labcyte.com
   www.labcyte.com
Multiple Locations:   
Congressional District:   17
County:   Santa Clara

Public Profile

Formerly dba PicoLiter Inc., Lab­cyte Inc. is a lab­o­ra­tory instru­men­ta­tion com­pany with a novel approach to dis­pens­ing small vol­umes of liquids for life sci­ences appli­ca­tions. In January 2019,i t was announced that LabCyte had been acquired by BeckmanCoulter Lfe Sciences. Designated acoustic droplet ejection (ADE) technology, LabCyte's acoustic dis­pens­ing tech­nol­ogy uses a focused beam of acoustic energy to eject nanoliter-??scale droplets of fluid from one plate to another, with high accu­racy at low vol­umes and reduced con­sum­ables costs. The company offers echo liquid handling products that enables the use of microwell plates, which decreases the amount of assay reagent required for tests; POD 810, a plate assembler and plate-on-demand integrated system that comprise plate storage, robotics, controller software and optional bulk filler, plate centrifuge, and plate sealer to set up plates; and Portrait 630, a reagent multi-spotter to deposit MALDI matrix and other reagents onto tissue sections and other samples for precision MALDI imaging mass spectrometry. It also provides consumables, such as microplates for DMSO and aqueous applications; and echo dose-response software that automates the process of diluting compounds for creating dose-response curves, and enables preparation of various concentrations in assay plates from nanoliter volumes of compound in source plates. In addition, the company offers echo cherry pick software to import pick-lists to find and transfer compounds that are distributed among the source plates, as well as to consolidate compounds selected from various source plates into a destination plate. It offers its products for various applications in the fields of compound management, genomics, proteomics, particle manufacturing, imaging mass spectrometry, and live-cell transfer. In January 2008, Labcyte bought Irish firm Allegro Technologies providing them a useful European presence

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
1 NIH $195,786
High Thoughput Biomarker Verification by Maldi-Ms

Key People / Management

  Mark D Fischer-Colbrie -- President; Chief Executive Officer

  Richard N Ellson -- Founder & Chief Technology Officer

  Michael F Miller -- Vice President, Product Development